Product information and disease descriptionProduct descriptionProduct information
Access and distribution
5 evidence topics · 7 sources
Current access: clinical trials only; no expanded access
Commercial build-out: field medical, market access, and strategic account teams
Treatment centers: HDSA Centers of Excellence and stereotactic surgical infrastructure
Neurosurgical administration requirements
Manufacturing supply through Genezen
Specialty distribution, risk evaluation and mitigation strategy, and payer coverage
No evidence found.